SPINA, Valeria Romina
 Distribuzione geografica
Continente #
NA - Nord America 923
EU - Europa 886
AS - Asia 226
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 3
Totale 2.048
Nazione #
US - Stati Uniti d'America 920
IE - Irlanda 281
SE - Svezia 165
DE - Germania 163
IT - Italia 97
UA - Ucraina 96
CN - Cina 77
IN - India 50
HK - Hong Kong 47
FI - Finlandia 45
SG - Singapore 39
GB - Regno Unito 19
EU - Europa 10
IR - Iran 10
BE - Belgio 4
AL - Albania 3
CA - Canada 3
NL - Olanda 3
CH - Svizzera 2
CL - Cile 2
FR - Francia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
PE - Perù 1
PL - Polonia 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 2.048
Città #
Dublin 281
Jacksonville 188
Chandler 104
Dearborn 90
Wilmington 84
Piemonte 48
Hong Kong 46
Ann Arbor 36
Lawrence 33
Princeton 33
Beijing 31
Boardman 28
Bremen 24
San Mateo 24
Singapore 23
Ashburn 20
Andover 13
Grafing 12
Hefei 12
Düsseldorf 8
Nanjing 7
Woodbridge 7
Houston 5
Kunming 5
Leawood 5
Norwalk 5
Brussels 4
Casalecchio Di Reno 4
Florence 4
Leipzig 4
Zanjan 4
Berlin 3
Guangzhou 3
Milan 3
Sacramento 3
Seattle 3
Trieste 3
Asti 2
Bangalore 2
Fairfield 2
Helsinki 2
Jinan 2
San Mauro Torinese 2
Santa Clara 2
Shaoxing 2
Shenyang 2
Tirana 2
Trecastagni 2
Trento 2
Winnipeg 2
Wuhan 2
Adliswil 1
Auburn Hills 1
Augusta 1
Baoding 1
Bologna 1
Brno 1
Cardano 1
Cassano Magnago 1
Chengdu 1
Colle 1
Dallas 1
Denia 1
Fuzhou 1
Gattico 1
Grafenhausen 1
Gunzenhausen 1
Hanover 1
Hebei 1
Henderson 1
Hyderabad 1
Kemerovo 1
Kocaeli 1
Köln 1
Lima 1
London 1
Modena 1
Monmouth Junction 1
Naaldwijk 1
Nanchang 1
Ngau Tau Kok 1
Nice 1
Palmetto 1
Perugia 1
Quarto D'asti 1
Redmond 1
Rome 1
Storrs Mansfield 1
Strasbourg 1
Taiyuan 1
Torino 1
Toronto 1
Treviso 1
Turin 1
Valdagno 1
Visp 1
Wenzhou 1
Yerevan 1
Zhengzhou 1
Totale 1.286
Nome #
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 111
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 102
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 100
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 77
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 76
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 73
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 72
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 71
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 70
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 70
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 69
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 69
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 66
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 64
The genetics of nodal marginal zone lymphoma 64
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 64
Biology and treatment of Richter syndrome 63
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 62
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 61
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 61
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 57
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 56
Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis 55
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 55
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study 55
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 51
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 50
Liquid biopsy in lymphoma 46
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients 45
Methods for Measuring ctDNA in Lymphomas 39
null 37
Genetic and phenotypic attributes of splenic marginal zone lymphoma 36
Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses 30
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 27
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 8
Totale 2.112
Categoria #
all - tutte 11.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020369 0 0 0 0 57 53 77 30 38 76 37 1
2020/2021243 37 10 33 2 35 5 33 11 34 10 33 0
2021/2022268 3 2 24 34 28 1 26 6 16 21 47 60
2022/2023648 36 27 58 7 53 64 20 38 298 2 24 21
2023/2024232 25 13 16 4 30 1 47 13 0 1 16 66
2024/202542 11 3 9 7 12 0 0 0 0 0 0 0
Totale 2.112